Mast cell–derived plasminogen activator inhibitor type 1 promotes airway inflammation and remodeling in a murine model of asthma

Ara Jo, Sun H. Lee, Dong Young Kim, Seung Jae Hong, Michael N. Teng, Narasaiah Kolliputi, Richard F. Lockey, Robert P. Schleimer, Seong H. Cho

Research output: Contribution to journalArticlepeer-review

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)294-297.e5
JournalJournal of Allergy and Clinical Immunology
Volume142
Issue number1
DOIs
StatePublished - Jul 2018

Funding

Supported by American Heart Association grant 11SDG7590063 and National Institutes of Health grant 1K23AI110731. This material is the result of work supported with resources and the use of facilities at the James A. Haley Veterans' Hospital. The contents do not represent the views of the Department of Veterans Affairs or the United States Government. Disclosure of potential conflict of interest: R. P. Schleimer has received grants from the National Institutes of Health (NIH); has consultant arrangements with Intersect ENT, GlaxoSmithKline, Allakos, Aurasense, Merck, BioMarck, Sanofi, AstraZeneca/MedImmune, Genentech, Exicure, and Otsuka; and has stock/stock options in Allakos, Aurasense, BioMarck, and Exicure. S. H. Cho has received grants from the American Heart Association, the NIH, and Sanofi and has received personal fees from Sanofi. The rest of the authors declare that they have no relevant conflicts of interest.

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this